<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunogenetics</journal-id><journal-title-group><journal-title>Immunogenetics</journal-title></journal-title-group><issn pub-type="ppub">0093-7711</issn><issn pub-type="epub">1432-1211</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19936734</article-id><article-id pub-id-type="publisher-id">408</article-id><article-id pub-id-type="doi">10.1007/s00251-009-0408-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Distribution of killer cell immunoglobulin-like receptors (<italic>KIR</italic>) and their HLA-C ligands in two Iranian populations</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Hiby</surname><given-names>Susan E.</given-names></name><address><phone>+44-1223-333729</phone><fax>+44-1223-765065</fax><email>seh1002@cam.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ashrafian-Bonab</surname><given-names>Maziar</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Farrell</surname><given-names>Lydia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Single</surname><given-names>Richard M.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Balloux</surname><given-names>Francois</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Carrington</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Moffett</surname><given-names>Ashley</given-names></name><address><email>am485@cam.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP UK </aff><aff id="Aff2"><label>2</label>Department of Biological Sciences, University of Portsmouth, King Henry Building, King Henry 1 Street, Portsmouth, UK </aff><aff id="Aff3"><label>3</label>Department of Mathematics and Statistics, University of Vermont, Burlington, VT USA </aff><aff id="Aff4"><label>4</label>Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, MRC Centre for Outbreak Analysis and Modelling, St. Mary&#x02019;s Campus, Norfolk Place, London, W2 1PG UK </aff><aff id="Aff5"><label>5</label>Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD USA </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>11</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>11</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2010</year></pub-date><volume>62</volume><issue>2</issue><fpage>65</fpage><lpage>73</lpage><history><date date-type="received"><day>12</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="en"><p>Killer cell immunoglobulin-like receptors (<italic>KIR</italic>) gene frequencies vary between populations and contribute to functional variation in immune responses to viruses, autoimmunity and reproductive success. This study describes the frequency distribution of 12 variable <italic>KIR</italic> genes and their HLA-C ligands in two Iranian populations who have lived for many generations in different environments: the Azerbaijanis at high altitude and the Jonobi people at sea level. The results are compared with those published for other human populations and a large group of English Caucasians. Differences were seen in <italic>KIR</italic> and <italic>HLA-C</italic> group frequencies, in linkage disequilibrium and inhibitory/activating <italic>KIR</italic> ratios between the groups. Similarities with geographically close populations in the frequencies of the <italic>KIR</italic> A and B haplotypes and <italic>KIR</italic> AA genotype reflected their common ancestry. The extreme variability of the <italic>KIR</italic> gene family and their HLA-C ligands is highlighted and their importance in defining differences between geographically and culturally isolated communities subject to different environmental pressures who come from the same ethnic grouping.</p></abstract><kwd-group><title>Keywords</title><kwd><italic>KIR</italic></kwd><kwd><italic>HLA-C</italic></kwd><kwd>Genotyping</kwd><kwd>Iranian</kwd><kwd>Azerbaijanis</kwd><kwd>Jonobi</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Natural killer (NK) cells are essential components of the innate immune system and act in the first line of defence against infection, play a role in tumour surveillance and are involved in placental development. Functionally, they are controlled by activating and inhibitory receptors (Colucci et al. <xref ref-type="bibr" rid="CR5">2003</xref>; Lanier <xref ref-type="bibr" rid="CR17">2008</xref>; McQueen and Parham <xref ref-type="bibr" rid="CR21">2002</xref>) and in humans the Killer cell Immunoglobulin-like Receptors (KIR) are of central importance in distinguishing normal healthy self cells from diseased or allogeneic targets. HLA class I molecules are ligands for some of the KIR and can trigger signals to inhibit effector function of the NK cells or conversely to stimulate killing or cytokine production (Colonna et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Long et al. <xref ref-type="bibr" rid="CR18">2001</xref>). The <italic>KIR</italic> genes and the genes for their HLA class I ligands reside on different chromosomes and probably constitute the most diverse loci in the human genome. Indeed, the <italic>KIR</italic> region is clearly undergoing rapid evolution and selection and only the most closely related individuals will share identical <italic>KIR</italic> genotypes (Khakoo et al. <xref ref-type="bibr" rid="CR14">2000</xref>; Parham <xref ref-type="bibr" rid="CR26">2005</xref>; Shilling et al. <xref ref-type="bibr" rid="CR33">2002</xref>). The diversity of the <italic>KIR</italic> region is achieved by both polymorphism at individual <italic>KIR</italic> gene loci as well as variable gene content. The framework <italic>KIR</italic> genes (3<italic>DL3</italic>, <italic>2DL4</italic> and <italic>3DL2</italic>) are present in nearly all individuals. Thirteen additional <italic>KIR</italic> genes have been characterised encoding five inhibitory receptors (<italic>3DL1</italic>, <italic>2DL1&#x02013;3</italic> and <italic>2DL5</italic>) and six activating KIR (<italic>2DS1&#x02013;5</italic>, <italic>3DS1</italic>). There are also two pseudogenes (<italic>2DP1</italic> and <italic>3DP1</italic>) that encode no cell surface receptors. Although <italic>KIR</italic> genotypes can vary markedly, these can be simplified into two broad categories comprised of A and/or B haplotypes. The simpler A haplotype has 7 <italic>KIR</italic> genes mainly coding for the inhibitory type (<italic>3DL1&#x02013;3</italic>, <italic>2DL1</italic> and <italic>2DL3</italic>) and a single <italic>KIR</italic> gene, <italic>2DS4</italic>, coding for an activating receptor. <italic>KIR2DS4</italic> is frequently represented by alleles with a frame-shifting deletion that abrogates the activating function of the receptor. The B haplotype has a more variable content with additional <italic>KIR</italic> genes (<italic>2DS1&#x02013;3</italic>, <italic>2DS5</italic>, <italic>3DS1</italic>, <italic>2DL2</italic> and <italic>2DL5</italic>) chiefly coding for activating receptors. In addition, the B haplotype can be divided into two halves, which are centromeric or telomeric to the centrally placed framework locus, <italic>2DL4</italic> (Yawata et al. <xref ref-type="bibr" rid="CR35">2002</xref>). These two halves were deduced from linkage disequilibrium studies and appear to be under differing selection pressures (Yawata et al. <xref ref-type="bibr" rid="CR36">2006</xref>). Similarly the numerous HLA-C alleles fall into one of two categories, C1 and C2, as recognized by the NK cell through the KIR receptors.</p><p>A number of studies of human populations world-wide have shown differences in <italic>KIR</italic> frequencies and haplotypes correlating with ethnicity, migration routes out of Africa and relative population isolation (Denis et al. <xref ref-type="bibr" rid="CR6">2005</xref>; Gendzekhadze et al. <xref ref-type="bibr" rid="CR8">2006</xref>; Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>; Norman et al. <xref ref-type="bibr" rid="CR24">2002</xref>; Rajalingam et al. <xref ref-type="bibr" rid="CR29">2008</xref>; Rayes et al. <xref ref-type="bibr" rid="CR30">2008</xref>; Single et al. <xref ref-type="bibr" rid="CR31">2007</xref>). In the Middle East, the <italic>KIR</italic> frequencies are similar to those found in Caucasian populations whilst <italic>KIR</italic> genotypes in Indians or Pakistanis show a tendency towards an increase in <italic>KIR</italic> B haplotypes. Interestingly, the Parsis who migrated from Persia to North India over 1,000&#x000a0;years ago differ from their North Indian neighbours but show close similarities to <italic>KIR</italic> genotypes in Maharashtrians who settled in North India in ancient times and have their own language (Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>). Until recently there had been no data available for Iranian populations which left a gap, geographically speaking, between the near-East (Mahfouz et al. <xref ref-type="bibr" rid="CR19">2006</xref>; Rayes et al. <xref ref-type="bibr" rid="CR30">2008</xref>) and Pakistan and India (Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>; Norman et al. <xref ref-type="bibr" rid="CR24">2002</xref>; Rajalingam et al. <xref ref-type="bibr" rid="CR28">2002</xref>) in reported <italic>KIR</italic> variation.</p><p>We have now genotyped samples from two distinct Iranian populations the Azerbaijanis and the Jonobi people and compared our results with those populations that are geographical neighbours as well as an English Caucasian group. The Azerbaijanis have lived for many generations at high altitude (above 2,400&#x000a0;m) in East Azerbaijan and Ardabil provinces. The Jonobi people from Hormozgan province and Balochistan live at sea level along the shores of the Persian Gulf and Oman Sea (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). In epidemiological studies, KIR and HLA ligand combinations have been shown to be important in the pathogenesis of certain viral infections such as HIV and HCV (Khakoo et al. <xref ref-type="bibr" rid="CR15">2004</xref>; Martin et al. <xref ref-type="bibr" rid="CR20">2002</xref>), in autoimmune diseases (Gardiner <xref ref-type="bibr" rid="CR7">2008</xref>; Nelson et al. <xref ref-type="bibr" rid="CR22">2004</xref>) and in reproductive fitness (Hiby et al. <xref ref-type="bibr" rid="CR10">2004</xref>, <xref ref-type="bibr" rid="CR11">2008</xref>; Parham <xref ref-type="bibr" rid="CR25">2004</xref>). We therefore typed our two Iranian populations for the12 <italic>KIR</italic> genes characterised by their variable presence and also identified the HLA-C groups, KIR ligands C1 and C2, carried by each individual. The Iranian results were compared to our Caucasian population and to other geographically close populations described in the literature. <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Ethnographic regions of Iran showing the two populations genotyped for KIR and HLA-C groups. Borders in the figure roughly correspond to cultural regions based on ethnicity and language. From Ashrafian-Bonab et al. <xref ref-type="bibr" rid="CR3">2007</xref>. Azerbaijanis traditionally live at &#x0003e;2,400&#x000a0;m, the Jonobi live at sea level in the Hormozgan and Baluchistan provinces</p></caption><graphic xlink:href="251_2009_408_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Study subjects</title><p>Blood samples were collected from unrelated adult males from two isolated Iranian communities as described (Ashrafian-Bonab et al. <xref ref-type="bibr" rid="CR3">2007</xref>). Marrying out of these communities is not common practice and they are very different in terms of culture and language. Samples were randomly collected from consenting volunteers to ensure an unbiased sampling strategy. Ethnic information was obtained on the place of birth of the subject and the place of birth of their parents and grandparents (Ashrafian-Bonab et al. <xref ref-type="bibr" rid="CR3">2007</xref>). One hundred samples from both populations were analysed in this study. Ethical approval was obtained from the Iranian Ministry of Health and the Iranian Cultural Heritage Organization.</p><p>Blood samples were taken from 584 healthy English Caucasian primiparous women and their male partners. Informed written consent and Local Ethics Committees' approval were obtained.</p></sec><sec id="Sec4"><title>DNA isolation and genotyping</title><p>DNA from the Iranian samples was extracted using the PAXgene blood DNA kit (Preanalytix, GmbH, Germany). Genomic DNA from the Caucasian cohort was isolated from 5 ml of blood using the QIAamp DNA Maxi Blood Kit (Qiagen, Crawley, UK). PCR-SSP was used to amplify the genomic DNA for presence or absence of the 12 variable <italic>KIR</italic> genes coding for the inhibitory KIR, 2DL1, 2DL2, 2DL3, 2DL5 and 3DL1 and the activating KIR, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DS1 and the pseudogene, <italic>2DP1</italic>. <italic>KIR2DS4</italic> alleles were also identified as being of the full-length type or having the 22bp deletion that would negate cell-surface expression, sometimes referred to as <italic>KIR1D</italic>. Two pairs of PCR primers were selected for each gene or allele to give relatively short amplicons of 100 to 800bp as previously described (Hiby et al. <xref ref-type="bibr" rid="CR10">2004</xref>). <italic>HLA-C</italic> was also genotyped as group C1 and/or group C2 as recognised by NK cells through the KIR receptors. The method used to define these groups by PCR-SSP was as previously described (Hiby et al. <xref ref-type="bibr" rid="CR11">2008</xref>).</p></sec><sec id="Sec5"><title>Data analysis and statistical methods</title><p>Carrier frequency was calculated by direct counting of individuals possessing at least one copy of the gene (individuals heterozygous for a <italic>KIR</italic> gene cannot be distinguished from those that are homozygous without family members, who were not available for this study). <italic>KIR</italic> gene frequency estimates were calculated using the equation <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\text{KGF}} = {\text{1}} - \surd \left( {{\text{1}} - {\text{f}}} \right) $$\end{document}</tex-math><inline-graphic xlink:href="251_2009_408_Article_IEq1.gif"/></alternatives></inline-formula> where f is the carrier frequency. Frequency of A and B haplotypes was deduced by defining the A haplotype as having the variable genes <italic>2DL1-2DL3-3DL1-2DS4</italic> only. The presence of the B haplotype would then be recognised by detection of any of the other <italic>KIR</italic> genes. Fisher's exact test was used to calculate <italic>p</italic> values for the comparison of carrier frequencies. LD coefficients for two-locus associations were calculated for unrelated Azerbaijani and Jonobi individuals according to Imanishi et al. (<xref ref-type="bibr" rid="CR12">1991</xref>). The statistical significance of LD was calculated using Fisher's exact test. <italic>KIR2DL2/2DL3</italic> and <italic>KIR3DL1/3DS1</italic> allelic pairs and the HLA-C groups, C1 and C2, were found to be in Hardy&#x02013;Weinberg equilibrium in all three populations.</p></sec></sec><sec id="Sec6"><title>Results and discussion</title><sec id="Sec7"><title>KIR and HLA-C group carrier frequencies</title><p>Only those <italic>KIR</italic> genes (<italic>n</italic>&#x02009;=&#x02009;12) that were known to have variable occurrence were typed and thus a measure of gene content could be obtained for each individual. The framework genes, <italic>KIR3DL3</italic>, <italic>3DL2</italic>, and <italic>2DL4</italic> as well as the pseudogene <italic>3DP1</italic>were assumed to be present in all individuals as seen for most other populations. Carrier and estimated gene frequencies are given in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> together with <italic>KIR</italic> frequencies from geographically close populations taken from the literature and from our English Caucasian cohort. The prevalence of the most common <italic>KIR</italic> AA genotype and that of the <italic>HLA-C2</italic> group is also given. <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Comparison of observed KIR frequencies (carriers) and estimated KIR gene frequencies with HLA-C2 group frequency in the Iranian, other Asian populations and an English Caucasian cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Population</th><th>KIR gene</th><th>2DL1</th><th>2DL2</th><th>2DL3</th><th>2DL5</th><th>3DL1</th><th>2DS1</th><th>2DS2</th><th>2DS3</th><th>2DS4</th><th>2DS5</th><th>3DS1</th><th>2DP1</th><th>KIRAA genotype%</th><th>HLA-C2 group %</th></tr></thead><tbody><tr><td rowspan="2">Caucasoid<sup>a</sup> (<italic>n</italic>&#x02009;=&#x02009;584)</td><td>Carrier frequency (%)</td><td char="." align="char">96.2</td><td char="." align="char">52.9</td><td char="." align="char">89.7</td><td char="." align="char">55.5</td><td char="." align="char">94.4</td><td char="." align="char">43.6</td><td char="." align="char">53.4</td><td char="." align="char">29.5</td><td char="." align="char">94.3</td><td char="." align="char">36.3</td><td char="." align="char">44.4</td><td char="." align="char">96.2</td><td>27.6</td><td>32.6</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.83</td><td char="." align="char">.31</td><td char="." align="char">.72</td><td char="." align="char">.33</td><td char="." align="char">.78</td><td char="." align="char">.25</td><td char="." align="char">.31</td><td char="." align="char">.15</td><td char="." align="char">.78</td><td char="." align="char">.21</td><td char="." align="char">.26</td><td char="." align="char">.83</td><td/><td/></tr><tr><td rowspan="2">Palestine<sup>b</sup> (<italic>n</italic>&#x02009;=&#x02009;105)</td><td>Carrier frequency %</td><td char="." align="char">97</td><td char="." align="char">62</td><td char="." align="char">85</td><td char="." align="char">63</td><td char="." align="char">88</td><td char="." align="char">44</td><td char="." align="char">64</td><td char="." align="char">37</td><td char="." align="char">88</td><td char="." align="char">27</td><td char="." align="char">39</td><td>ND</td><td>23</td><td>24</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.83</td><td char="." align="char">.38</td><td char="." align="char">.61</td><td char="." align="char">.39</td><td char="." align="char">.65</td><td char="." align="char">.25</td><td char="." align="char">.40</td><td char="." align="char">.21</td><td char="." align="char">.65</td><td char="." align="char">.14</td><td char="." align="char">.22</td><td/><td/><td/></tr><tr><td rowspan="2">Lebanese<sup>b</sup> (<italic>n</italic>&#x02009;=&#x02009;120)</td><td>Carrier frequency (%)</td><td char="." align="char">99</td><td char="." align="char">60</td><td char="." align="char">88</td><td>ND</td><td char="." align="char">96</td><td char="." align="char">41</td><td char="." align="char">59</td><td char="." align="char">38</td><td char="." align="char">95</td><td char="." align="char">31</td><td char="." align="char">36</td><td char="." align="char">ND</td><td>26</td><td>31</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.91</td><td char="." align="char">.36</td><td char="." align="char">.66</td><td/><td char="." align="char">.80</td><td char="." align="char">.23</td><td char="." align="char">.36</td><td char="." align="char">.21</td><td char="." align="char">.78</td><td char="." align="char">.17</td><td char="." align="char">.20</td><td/><td/><td/></tr><tr><td rowspan="2">Jonobi<sup>a</sup> (<italic>n</italic>&#x02009;=&#x02009;100)</td><td>Carrier frequency (%)</td><td char="." align="char">97</td><td char="." align="char">54</td><td char="." align="char">85</td><td char="." align="char">62</td><td char="." align="char">93</td><td char="." align="char">42</td><td char="." align="char">57</td><td char="." align="char">42</td><td char="." align="char">93</td><td char="." align="char">36</td><td char="." align="char">37</td><td char="." align="char">97</td><td>26</td><td>57</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.83</td><td char="." align="char">.32</td><td char="." align="char">.61</td><td char="." align="char">.38</td><td char="." align="char">.74</td><td char="." align="char">.24</td><td char="." align="char">.34</td><td char="." align="char">.24</td><td char="." align="char">.74</td><td char="." align="char">.20</td><td char="." align="char">.21</td><td char="." align="char">.83</td><td/><td/></tr><tr><td rowspan="2">Azerbaijani<sup>a</sup> (<italic>n</italic>&#x02009;=&#x02009;100)</td><td>Carrier frequency (%)</td><td char="." align="char">99</td><td char="." align="char">56</td><td char="." align="char">84</td><td char="." align="char">64</td><td char="." align="char">97</td><td char="." align="char">49</td><td char="." align="char">58</td><td char="." align="char">42</td><td char="." align="char">97</td><td char="." align="char">38</td><td char="." align="char">47</td><td char="." align="char">99</td><td>23</td><td>44</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.91</td><td char="." align="char">.34</td><td char="." align="char">.60</td><td char="." align="char">.39</td><td char="." align="char">.83</td><td char="." align="char">.29</td><td char="." align="char">.35</td><td char="." align="char">.24</td><td char="." align="char">.83</td><td char="." align="char">.21</td><td char="." align="char">.27</td><td char="." align="char">.91</td><td/><td/></tr><tr><td rowspan="2">Karachi S. Asians<sup>c</sup> (<italic>n</italic>&#x02009;=&#x02009;78)</td><td>Carrier frequency (%)</td><td char="." align="char">90</td><td char="." align="char">67</td><td char="." align="char">91</td><td char="." align="char">78</td><td char="." align="char">81</td><td char="." align="char">60</td><td char="." align="char">69</td><td char="." align="char">45</td><td char="." align="char">72</td><td char="." align="char">48</td><td char="." align="char">56</td><td>ND</td><td>11.5</td><td/></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.68</td><td char="." align="char">.42</td><td char="." align="char">.70</td><td char="." align="char">.53</td><td char="." align="char">.56</td><td char="." align="char">.37</td><td char="." align="char">.45</td><td char="." align="char">.26</td><td char="." align="char">.47</td><td char="." align="char">.28</td><td char="." align="char">.34</td><td/><td/><td/></tr><tr><td rowspan="2">Parsis<sup>d</sup> (<italic>n</italic>&#x02009;=&#x02009;145)</td><td>Carrier frequency (%)</td><td char="." align="char">99.3</td><td char="." align="char">62.8</td><td char="." align="char">81.9</td><td char="." align="char">71.0</td><td char="." align="char">87.4</td><td char="." align="char">62.8</td><td char="." align="char">62.8</td><td char="." align="char">53.8</td><td char="." align="char">86.1</td><td char="." align="char">51.0</td><td char="." align="char">62.2</td><td char="." align="char">99.3</td><td>24.1</td><td>47.4</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.92</td><td char="." align="char">.39</td><td char="." align="char">.58</td><td char="." align="char">.46</td><td char="." align="char">.65</td><td char="." align="char">.39</td><td char="." align="char">.39</td><td char="." align="char">.32</td><td char="." align="char">.63</td><td char="." align="char">.30</td><td char="." align="char">.39</td><td char="." align="char">.92</td><td/><td/></tr><tr><td rowspan="2">N Indians<sup>e</sup> (<italic>n</italic>&#x02009;=&#x02009;72)</td><td>Carrier frequency (%)</td><td char="." align="char">87.5</td><td char="." align="char">79.2</td><td char="." align="char">65.3</td><td char="." align="char">79.2</td><td char="." align="char">87.5</td><td char="." align="char">54.2</td><td char="." align="char">62.5</td><td char="." align="char">43.1</td><td char="." align="char">80.6</td><td char="." align="char">47.2</td><td char="." align="char">38.9</td><td>ND</td><td>5.6</td><td>31.3</td></tr><tr><td>Estimated gene frequency</td><td char="." align="char">.65</td><td char="." align="char">.54</td><td char="." align="char">.41</td><td char="." align="char">.54</td><td char="." align="char">.65</td><td char="." align="char">.32</td><td char="." align="char">.39</td><td char="." align="char">.25</td><td char="." align="char">.56</td><td char="." align="char">.73</td><td char="." align="char">.22</td><td/><td/><td/></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Populations genotyped by the authors</p><p><sup>b</sup>Norman et al. <xref ref-type="bibr" rid="CR23">2001</xref>, <xref ref-type="bibr" rid="CR24">2002</xref>, Mahfouz et al. <xref ref-type="bibr" rid="CR19">2006</xref></p><p><sup>c</sup>Norman et al. <xref ref-type="bibr" rid="CR24">2002</xref></p><p><sup>d</sup>Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref></p><p><sup>e</sup>Rajalingam et al. <xref ref-type="bibr" rid="CR28">2002</xref>. (Estimated gene frequency from <inline-formula id="IEq2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\text{GF}} = {\text{1}} - \surd {\text{1}} - {\text{f}} $$\end{document}</tex-math><inline-graphic xlink:href="251_2009_408_Article_IEq2.gif"/></alternatives></inline-formula> where f is the carrier frequency)</p></table-wrap-foot></table-wrap></p><p>Notably, there were higher frequencies of a number of <italic>KIR</italic>; both those coding for inhibitory receptors, <italic>KIR2DL1</italic> and <italic>KIR3DL1</italic> and activating receptors, <italic>KIR2DS1</italic>, <italic>2DS4</italic> and <italic>3DS1</italic> in the Azerbaijanis compared with the Jonobi population. The genes coding for activating KIR, <italic>2DS1</italic> and <italic>3DS1</italic> are in strong linkage disequilibrium to each other and have been implicated in resistance to infection and in reproductive success (Hiby et al. <xref ref-type="bibr" rid="CR11">2008</xref>; Martin et al. <xref ref-type="bibr" rid="CR20">2002</xref>; Qi et al. <xref ref-type="bibr" rid="CR27">2006</xref>). The <italic>KIR2DS4</italic> allele coding for the full-length cell surface receptor was present at equal frequency in the two populations (carrier frequency being 29% in Azerbaijanis, 28% in Jonobis, not shown), the deleted form was more frequent in the Azerbaijanis. Expression of inhibitory KIR has been shown to be important in determining the responsiveness of NK cells to stimuli (Anfossi et al. <xref ref-type="bibr" rid="CR1">2006</xref>; Yawata et al. <xref ref-type="bibr" rid="CR37">2008</xref>).</p><p>Overall the Jonobi population more closely resembled the more westerly Palestinian and Lebanese people than did the Azerbaijanis but neither had such high frequencies of the activating <italic>KIR</italic> genes as seen in the more easterly populations of the Karachi South Asians and the Parsis.</p><p>Notably <italic>KIR2DS3</italic> was present at high frequency in both Iranian populations (42% carriers) compared to our Caucasian population (30% carriers). This relatively high frequency of <italic>2DS3</italic> was also observed for neighbouring population groups from Palestine (Norman et al. <xref ref-type="bibr" rid="CR23">2001</xref>) to the Parsis in India (Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>).</p><p>The <italic>KIR</italic> A and B haplotypes were deduced from the individual <italic>KIR</italic> gene frequencies as described. Overall there was a balance in the frequencies of the A and B haplotypes as has been reported in all populations analysed (Rajalingam et al. <xref ref-type="bibr" rid="CR29">2008</xref>). The Jonobi people had 56% A haplotypes and the Azerbaijanis, 53%. Our Caucasian population had 59% A haplotypes to 41% B haplotypes. From the ratio of frequencies of inhibitory (<italic>2DL1, 2DL2, 2DL3, 3DL1</italic>) to activating (<italic>2DS1, 2DS2, 2DS4</italic> full length, <italic>3DS1</italic>) <italic>KIR</italic> genes reported to have HLA class I ligands the Azerbaijanis are deviated more towards activation (ratio inhibitory to activating <italic>KIR</italic> 1.85/1) than the Jonobi people (ratio 2.01/1). The Caucasians gave a ratio with these <italic>KIR</italic> very similar to the Jonobi population of 2.04/1.</p><p>In addition there was a significantly higher frequency of the KIR ligand HLA-C2 in the Jonobis as compared to the Azerbaijanis (<italic>p</italic> value, 0.006) and the Caucasians (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) with a notably high carrier frequency of 57% (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The C2 frequency is also high in Parsis (47%). In addition, the data from our three populations fits well with the model of Single et al. (<xref ref-type="bibr" rid="CR31">2007</xref>) who depicted a negative correlation between <italic>KIR2DS1</italic> and its ligand HLA-C2 that provides good evidence for their co-evolution (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). <fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Correlation between KIR2DS1 and C-group 2 frequencies. Results for our populations are superimposed upon the global distribution. Each <italic>coloured circle</italic> represents a distinct population, with the colours identifying the geographic origin of the populations. The <italic>solid line</italic> represents the estimated regression line (Single et al. <xref ref-type="bibr" rid="CR31">2007</xref>).The Iranian and Caucasian population data reported here fits well with the study of Kulkarni et al. (<xref ref-type="bibr" rid="CR16">2008</xref>) The activating KIR2DS1 shows a negative correlation with its HLA-C2 ligand although this did not reach significance. <italic>Boxed letters</italic> denote our populations: <italic>C</italic> Caucasian, <italic>A</italic> Azerbaijani and <italic>J</italic> Jonobi. For comparison, <italic>NI</italic> North Indian, <italic>M</italic> Maharashtrian and <italic>P</italic> Parsis are also shown within the <italic>diamonds</italic></p></caption><graphic xlink:href="251_2009_408_Fig2_HTML" id="MO2"/></fig></p><p>Since writing this report, two publications on other Iranian populations have been released (Ashouri et al. <xref ref-type="bibr" rid="CR2">2009</xref> and Tajik et al. <xref ref-type="bibr" rid="CR34">2009</xref>). One reported on the general Iranian population selected from a number of cities (Tajik et al. <xref ref-type="bibr" rid="CR34">2009</xref>) and the second includes an Azeri population that was not selected on living at high altitude and indeed does not resemble our own Azerbaijani population in terms of the <italic>KIR</italic> frequencies (Ashouri et al. <xref ref-type="bibr" rid="CR2">2009</xref>). The possible confounding effect of racial admixture was suggested for this latter population by the authors.</p></sec><sec id="Sec8"><title>KIR genotype profiles</title><p>The Azerbaijanis and Jonobi people shared 16 <italic>KIR</italic> genotype profiles and 15 of these were also seen in the Caucasian population (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The <italic>KIR</italic> AA genotype was the most frequent in all three populations. The Azerbaijanis had seven profiles that were not found in the Jonobi people (five of these were seen in the Caucasians). In addition, the Jonobi people possessed 12 profiles not found in the Azerbaijanis and only four of these were seen in the Caucasians. The English Caucasian population had an additional 18 <italic>KIR</italic> profiles that were not seen in either Iranian population and these were uncommon genotypes present in one to four individuals only. The number of distinct profiles in the Azerbaijani, Jonobi and Caucasians numbered 23, 28 and 43, respectively. This would support the view that the Iranian populations were from relatively isolated populations as seen with the Parsis (19 profiles, Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>) and in contrast to the genetically diverse North Indians (47 profiles, Rajalingam et al. <xref ref-type="bibr" rid="CR28">2002</xref>) and our Caucasian population (Shifman et al. <xref ref-type="bibr" rid="CR32">2003</xref>). <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>KIR genotype profiles and frequencies for the two Iranian and an English Caucasian population. The Caucasian population had 18 unique profiles not seen in the Iranian populations; these were uncommon genotypes present in one to four individuals (not shown here)</p></caption><graphic xlink:href="251_2009_408_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec9"><title>KIR A and B haplotypes</title><p>Unusual <italic>KIR</italic> genotypes, with all the <italic>KIR</italic> A haplotype genes but with single additional genes of the B haplotype were observed. In the Azerbaijani population, two individuals possessed <italic>KIR2DS1</italic> with the A haplotype genes but no other B haplotype <italic>KIR</italic>. This has been observed in other populations at low frequency (Kulkarni et al. <xref ref-type="bibr" rid="CR16">2008</xref>). Another Azerbaijani individual had an additional <italic>KIR2DS2</italic> with the <italic>KIR</italic> A haplotype genes as reported in several Indian populations (Rajalingam et al. <xref ref-type="bibr" rid="CR29">2008</xref>). In addition a single Jonobi individual had the unusual combination of <italic>KIR</italic> AA genotype genes with a <italic>KIR2DL5</italic>gene. This has not been reported before.</p><p>The next most common genotype in the Azerbaijanis after <italic>KIR</italic> AA comprised both an A haplotype and a B haplotype which was characterised by presence of the, mainly activating, telomeric group of <italic>KIR</italic> genes: <italic>3DS1-2DL5-2DS5-2DS1</italic> (profile 2 shared, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). This was in contrast to the second most common in the Jonobi which had the A haplotype loci together with the centromeric B haplotype genes <italic>2DL2</italic> and <italic>2DS2</italic> (profile 4 shared, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p></sec><sec id="Sec10"><title>Linkage disequilibrium</title><p>Comparing linkage disequilibrium between pairs of <italic>KIR</italic> genes in the two Iranian populations reflected their different spread of <italic>KIR</italic> genotypes (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The Jonobi sample had 29 pairs of genes in significant positive or negative LD compared with the Azerbijani with 22 and this can be compared with the endogamous Parsis population with 39 pairs. The higher frequency of the <italic>KIR</italic> AA genotype in the Jonobi people was reflected in a more marked distinction between the LD values of the haplotype A and B <italic>KIR</italic> genes seen for this population. There were 13 pairs of genes that gave discordant results: eight pairs were in significant negative LD only in the Jonobi (<italic>3DS1-3DL1, 2DL5-3DL1, 2DS5-3DL1, 2DS1-3DL1, 2DS4-3DS1, 2DS4-2DL5, 2DS4-2DS5</italic> and <italic>2DS4-2DS1</italic>), whereas two pairs were in significant positive LD (<italic>2DP1-2DL3</italic> and <italic>2DL1-2DL3</italic>). Only three <italic>KIR</italic> gene pairs in the Azerbijani showed significance differences not found in the Jonobi with <italic>2DL3-2DL5, 2DL3-2DS5</italic> and <italic>2DL3-2DS1</italic> being in significant negative LD. Like the Parsis the Azerbijanis also showed an unusual lack of LD between <italic>KIR2DL3</italic> and <italic>KIR2DL1</italic> which are closely linked on the A haplotype and are reported to be in strong LD in all other published populations. The <italic>KIR2DL1</italic>*004 allele that resides on the B haplotype is not in LD with <italic>KIR2DL3</italic> so this may explain the results obtained if the Azerbaijanis possess an unusual high frequency of the B haplotype <italic>2DL1</italic> alleles. <italic>KIR2DL1</italic> allele typing would be required to confirm this. <fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Linkage disequilibrium analysis for 12 KIR genes in Azerbaijanis and Jonobi people. LD coefficients (<italic>empty triangle</italic>) and <italic>p</italic> values (<italic>p</italic>) on the <italic>upper triangle</italic> are for the Azerbaijanis. Values on the <italic>lower triangle</italic> are for the Jonobis. <italic>NS</italic> not significant</p></caption><graphic xlink:href="251_2009_408_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec11"><title>Summary</title><p>The two Iranian populations showed distinctive differences in <italic>KIR</italic> and <italic>HLA-C</italic> group carrier and genotype frequencies. Comparison with other genotyped populations to the west and east of Iran can now be made using this data. We also describe unusual <italic>KIR</italic> genotypes emphasising the great diversity and malleability of the <italic>KIR</italic> locus in human populations that may arise from selective pressures in response to pathogens, reproductive fitness or other factors in the environment. Our other studies indicate that <italic>KIR</italic> B telomeric genes are those lacking in Caucasian women who experience problems during pregnancy. Of particular interest in this regard are pregnancy and reproduction at high altitude: birth weight decreases with altitude and the risk of foetal growth restriction and pre-eclampsia are increased (Julian et al. <xref ref-type="bibr" rid="CR13">2007</xref>; Zamudio <xref ref-type="bibr" rid="CR38">2007</xref>). Furthermore, these observations are likely due directly to hypoxia at altitude, rather than economic status (Giussani et al. <xref ref-type="bibr" rid="CR9">2001</xref>). Importantly, those with high altitude ancestry are partially protected from this reduction in fetal growth compared with those who have settled in the area more recently (Julian et al. <xref ref-type="bibr" rid="CR13">2007</xref>). When comparing these two Iranian populations for the two polymorphic gene families the increased incidence of <italic>KIR</italic> B telomeric genes in the Azerbaijanis compared to the Jonobis is interesting because the incidence of hypertension in pregnancy and recurrent miscarriage is increased in these Iranians living at high altitude in data supplied by the Iranian Ministry of Health (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Whether differences in <italic>KIR</italic> can be ascribed to contrasting environments, especially adaptations to living at high and low altitude, can only be determined as data on other similar populations increases. <table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Reproductive problems in the two Iranian populations (data from the Iranian Ministry of Health)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Geographical area</th><th>East Azerbaijan and Ardabil</th><th>Hormozghan and Baluchistan</th></tr><tr><th>Population</th><th>Azerbaijanis</th><th>Jonobi</th></tr></thead><tbody><tr><td>Recurrent miscarriage or late pregnancy miscarriage</td><td char="." align="char">5.3%</td><td char="." align="char">3.2%</td></tr><tr><td>Low birth weight&#x0003c;2,500&#x000a0;g</td><td char="." align="char">6.9%</td><td char="." align="char">6.7%</td></tr><tr><td>Hypertension</td><td char="." align="char">12.5%</td><td char="." align="char">6.8%</td></tr><tr><td>Blurred vision and headache due to hypertension</td><td char="." align="char">4.9%</td><td char="." align="char">2.3%</td></tr></tbody></table></table-wrap></p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thank all the dedicated clinical and scientific staff who helped us to acquire the DNA samples used for this study and many thanks to the consenting subjects. The work was funded by the Wellcome Trust and the British Heart Foundation in the UK. This project has been funded in whole or in part with federal funds from the US National Cancer Institute (National Institutes of Health) under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anfossi</surname><given-names>N</given-names></name><name><surname>Andre</surname><given-names>P</given-names></name><name><surname>Guia</surname><given-names>S</given-names></name><name><surname>Falk</surname><given-names>CS</given-names></name><name><surname>Roetynck</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Human NK cell education by inhibitory receptors for MHC class I</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.06.013</pub-id><pub-id pub-id-type="pmid">16901727</pub-id></mixed-citation></ref><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashouri</surname><given-names>E</given-names></name><name><surname>Farjadian</surname><given-names>S</given-names></name><name><surname>Reed</surname><given-names>EF</given-names></name><name><surname>Ghaderi</surname><given-names>A</given-names></name><name><surname>Rajalingam</surname><given-names>R</given-names></name></person-group><article-title>KIR gene content diversity in four Iranian populations</article-title><source>Immunogenetics</source><year>2009</year><volume>61</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1007/s00251-009-0378-7</pub-id><pub-id pub-id-type="pmid">19521696</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafian-Bonab</surname><given-names>M</given-names></name><name><surname>Lawson Handley</surname><given-names>LJ</given-names></name><name><surname>Balloux</surname><given-names>F</given-names></name></person-group><article-title>Is urbanization scrambling the genetic structure of human populations? A case study</article-title><source>Heredity</source><year>2007</year><volume>98</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/sj.hdy.6800918</pub-id><pub-id pub-id-type="pmid">17106453</pub-id></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Moretta</surname><given-names>A</given-names></name><name><surname>Vely</surname><given-names>F</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group><article-title>A high resolution view of NK-cell receptors: structure and function</article-title><source>Immunol Today</source><year>2000</year><volume>21</volume><fpage>428</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/S0167-5699(00)01697-2</pub-id><pub-id pub-id-type="pmid">11012243</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colucci</surname><given-names>F</given-names></name><name><surname>Caliguri</surname><given-names>MA</given-names></name><name><surname>Santo</surname><given-names>JP</given-names></name></person-group><article-title>What does it take to make a natural killer</article-title><source>Nat Rev Immunol</source><year>2003</year><volume>3</volume><fpage>413</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1038/nri1088</pub-id><pub-id pub-id-type="pmid">12766763</pub-id></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>L</given-names></name><name><surname>Sivula</surname><given-names>J</given-names></name><name><surname>Gourraud</surname><given-names>PA</given-names></name><name><surname>Kerdudou</surname><given-names>N</given-names></name><name><surname>Chout</surname><given-names>R</given-names></name><name><surname>Ricard</surname><given-names>C</given-names></name><name><surname>Moisan</surname><given-names>JP</given-names></name><name><surname>Gagne</surname><given-names>K</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Bignon</surname><given-names>JD</given-names></name></person-group><article-title>Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion</article-title><source>Tissue Antigens</source><year>2005</year><volume>66</volume><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0039.2005.00473.x</pub-id><pub-id pub-id-type="pmid">16185321</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>CM</given-names></name></person-group><article-title>Killer cell immunoglobulin-like receptors on NK cells: the how, where and why</article-title><source>Int J Immunogenet</source><year>2008</year><volume>35</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18093180</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendzekhadze</surname><given-names>K</given-names></name><name><surname>Norman</surname><given-names>PJ</given-names></name><name><surname>Abi-Rached</surname><given-names>L</given-names></name><name><surname>Layrisse</surname><given-names>Z</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>High KIR diversity in Amerindians is maintained using few gene-content haplotypes</article-title><source>Immunogenetics</source><year>2006</year><volume>58</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s00251-006-0108-3</pub-id><pub-id pub-id-type="pmid">16738943</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giussani</surname><given-names>DA</given-names></name><name><surname>Phillips</surname><given-names>PS</given-names></name><name><surname>Anstee</surname><given-names>S</given-names></name><name><surname>Barker</surname><given-names>DJ</given-names></name></person-group><article-title>Effects of altitude versus economic status on birth weight and body shape at birth</article-title><source>Pediatr Res</source><year>2001</year><volume>49</volume><fpage>490</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1203/00006450-200104000-00009</pub-id><pub-id pub-id-type="pmid">11264431</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiby</surname><given-names>SE</given-names></name><name><surname>Walker</surname><given-names>JJ</given-names></name><name><surname>O'Shaughnessy</surname><given-names>KM</given-names></name><name><surname>Redman</surname><given-names>CW</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Moffett</surname><given-names>A</given-names></name></person-group><article-title>Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>957</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1084/jem.20041214</pub-id><pub-id pub-id-type="pmid">15477349</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiby</surname><given-names>SE</given-names></name><name><surname>Regan</surname><given-names>L</given-names></name><name><surname>Lo</surname><given-names>W</given-names></name><name><surname>Farrell</surname><given-names>L</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Moffett</surname><given-names>A</given-names></name></person-group><article-title>Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage</article-title><source>Hum Reprod</source><year>2008</year><volume>23</volume><fpage>972</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1093/humrep/den011</pub-id><pub-id pub-id-type="pmid">18263639</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="other">Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T (1991) Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T (eds) HLA: 1991 Proceedings of the eleventh International Histocompatibility Workshop and Conference, vol 1. Oxford University Press, New York, 6&#x02013;13 November 1991</mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julian</surname><given-names>CG</given-names></name><name><surname>Vargas</surname><given-names>E</given-names></name><name><surname>Armaza</surname><given-names>JF</given-names></name><name><surname>Wilson</surname><given-names>MJ</given-names></name><name><surname>Niermeyer</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>LG</given-names></name></person-group><article-title>High-altitude ancestry protects against hypoxia-associated reductions in fetal growth</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2007</year><volume>92</volume><fpage>372</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1136/adc.2006.109579</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakoo</surname><given-names>SI</given-names></name><name><surname>Rajalingam</surname><given-names>R</given-names></name><name><surname>Shum</surname><given-names>BP</given-names></name><name><surname>Weidenbach</surname><given-names>K</given-names></name><name><surname>Flodin</surname><given-names>L</given-names></name><name><surname>Muir</surname><given-names>DG</given-names></name><name><surname>Canavez</surname><given-names>F</given-names></name><name><surname>Cooper</surname><given-names>SL</given-names></name><name><surname>Valiante</surname><given-names>NM</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Rapid evolution of NK receptor systems demonstrated by comparison of chimpanzees and humans</article-title><source>Immunity</source><year>2000</year><volume>12</volume><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80219-8</pub-id><pub-id pub-id-type="pmid">10894168</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakoo</surname><given-names>SI</given-names></name><name><surname>Thio</surname><given-names>CL</given-names></name><name><surname>Martin</surname><given-names>MP</given-names></name><name><surname>Brooks</surname><given-names>CR</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Astemborski</surname><given-names>J</given-names></name><etal/></person-group><article-title>HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection</article-title><source>Science</source><year>2004</year><volume>305</volume><fpage>872</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1126/science.1097670</pub-id><pub-id pub-id-type="pmid">15297676</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>S</given-names></name><name><surname>Single</surname><given-names>MMP</given-names></name><name><surname>Rajalingam</surname><given-names>R</given-names></name><name><surname>Badwe</surname><given-names>R</given-names></name><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name></person-group><article-title>Comparison of the rapidly evolving KIR locus in Parsis and natives of India</article-title><source>Immunogenetics</source><year>2008</year><volume>60</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1007/s00251-008-0279-1</pub-id><pub-id pub-id-type="pmid">18351333</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname><given-names>L</given-names></name></person-group><article-title>Up on the tightrope: natural killer cell activation and inhibition</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/ni1581</pub-id><pub-id pub-id-type="pmid">18425106</pub-id></mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>EO</given-names></name><name><surname>Barber</surname><given-names>DF</given-names></name><name><surname>Burshtyn</surname><given-names>DN</given-names></name><name><surname>Faure</surname><given-names>M</given-names></name><name><surname>Peterson</surname><given-names>M</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Renard</surname><given-names>V</given-names></name><name><surname>Sandusky</surname><given-names>M</given-names></name><name><surname>Stebbins</surname><given-names>CC</given-names></name><name><surname>Wagtmann</surname><given-names>N</given-names></name><name><surname>Watzl</surname><given-names>C</given-names></name></person-group><article-title>Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)</article-title><source>Immunol Rev</source><year>2001</year><volume>181</volume><fpage>223</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1034/j.1600-065X.2001.1810119.x</pub-id><pub-id pub-id-type="pmid">11513144</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahfouz</surname><given-names>R</given-names></name><name><surname>Rayes</surname><given-names>R</given-names></name><name><surname>Mahfoud</surname><given-names>Z</given-names></name><name><surname>Bazarbachi</surname><given-names>A</given-names></name><name><surname>Zaatari</surname><given-names>G</given-names></name></person-group><article-title>Distribution of killer cell immunoglobulin-like receptors genotypes in the Lebanese population</article-title><source>Tissue Antigens</source><year>2006</year><volume>68</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0039.2006.00605.x</pub-id><pub-id pub-id-type="pmid">16774542</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MP</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Nelson</surname><given-names>GW</given-names></name><name><surname>Detels</surname><given-names>R</given-names></name><name><surname>Goedert</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Epistatic interaction between KIR3DS1 and HLA-B delays progression to Aids</article-title><source>Nat Genet</source><year>2002</year><volume>31</volume><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">12134147</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQueen</surname><given-names>KL</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Variable receptors controlling activation and inhibition of NK cells</article-title><source>Curr Opin Immunol</source><year>2002</year><volume>14</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(02)00380-1</pub-id><pub-id pub-id-type="pmid">12183162</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>GW</given-names></name><name><surname>Martin</surname><given-names>MP</given-names></name><name><surname>Gladman</surname><given-names>D</given-names></name><name><surname>Wade</surname><given-names>J</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name></person-group><article-title>Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>4273</fpage><lpage>4276</lpage><pub-id pub-id-type="pmid">15383555</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>PJ</given-names></name><name><surname>Stephens</surname><given-names>HAF</given-names></name><name><surname>Verity</surname><given-names>DH</given-names></name><name><surname>Chandanayingyong</surname><given-names>D</given-names></name><name><surname>Vaughan</surname><given-names>RW</given-names></name></person-group><article-title>Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups</article-title><source>Immunogenetics</source><year>2001</year><volume>52</volume><fpage>195</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1007/s002510000281</pub-id><pub-id pub-id-type="pmid">11220621</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>PJ</given-names></name><name><surname>Carrington</surname><given-names>CVF</given-names></name><name><surname>Byng</surname><given-names>M</given-names></name><name><surname>Maxwell</surname><given-names>LD</given-names></name><name><surname>Curran</surname><given-names>MD</given-names></name><name><surname>Stephens</surname><given-names>HAF</given-names></name><etal/></person-group><article-title>Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations</article-title><source>Genes Immun</source><year>2002</year><volume>3</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6363836</pub-id><pub-id pub-id-type="pmid">11960306</pub-id></mixed-citation></ref><ref id="CR25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>NK cells and trophoblasts: partners in pregnancy</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1084/jem.20041783</pub-id><pub-id pub-id-type="pmid">15492121</pub-id></mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>MHC class I molecules and KIRs in human history, health and survival</article-title><source>Nat Rev Immunol</source><year>2005</year><volume>5</volume><fpage>201</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/nri1570</pub-id><pub-id pub-id-type="pmid">15719024</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Mp</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Jacobson</surname><given-names>L</given-names></name><name><surname>Goedert</surname><given-names>JJ</given-names></name><name><surname>Buchbinder</surname><given-names>S</given-names></name><name><surname>Kirk</surname><given-names>GD</given-names></name><name><surname>O'Brien</surname><given-names>SJ</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name></person-group><article-title>KIR/HLA pleiotropism: protection against both HIV and opportunistic infections</article-title><source>PloS Pathog</source><year>2006</year><volume>2</volume><fpage>e79</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0020079</pub-id><pub-id pub-id-type="pmid">16933987</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajalingam</surname><given-names>R</given-names></name><name><surname>Krausa</surname><given-names>P</given-names></name><name><surname>Shilling</surname><given-names>HG</given-names></name><name><surname>Stein</surname><given-names>JB</given-names></name><name><surname>Balamurugan</surname><given-names>A</given-names></name><name><surname>McGinnis</surname><given-names>MD</given-names></name><name><surname>Cheng</surname><given-names>NW</given-names></name><name><surname>Mehra</surname><given-names>NK</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Distinctive KIR and HLA diversity in a panel of north Indian Hindus</article-title><source>Immunogenetics</source><year>2002</year><volume>53</volume><fpage>10009</fpage><lpage>1019</lpage></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajalingam</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Meenagh</surname><given-names>A</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Kavitha</surname><given-names>VJ</given-names></name><name><surname>Pavithra-Arulvani</surname><given-names>R</given-names></name><etal/></person-group><article-title>Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations</article-title><source>Immunogenetics</source><year>2008</year><volume>60</volume><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1007/s00251-008-0286-2</pub-id><pub-id pub-id-type="pmid">18369612</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayes</surname><given-names>R</given-names></name><name><surname>Bazarbachi</surname><given-names>A</given-names></name><name><surname>Khazen</surname><given-names>G</given-names></name><name><surname>Sabbagh</surname><given-names>A</given-names></name><name><surname>Zaatari</surname><given-names>G</given-names></name><name><surname>Mahfouz</surname><given-names>R</given-names></name></person-group><article-title>Natural killer cell immunoglobulin-like receptors (KIR) genotypes in two Arab populations: will KIR become a genetic landmark between nations?</article-title><source>Mol Biol Rep</source><year>2008</year><volume>35</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1007/s11033-007-9074-6</pub-id><pub-id pub-id-type="pmid">17385087</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Single</surname><given-names>RM</given-names></name><name><surname>Martin</surname><given-names>MP</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Meyer</surname><given-names>D</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><name><surname>Kidd</surname><given-names>JR</given-names></name><name><surname>Kidd</surname><given-names>KK</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name></person-group><article-title>Global diversity and evidence for coevolution of KIR and HLA</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>1114</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.1038/ng2077</pub-id><pub-id pub-id-type="pmid">17694058</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shifman</surname><given-names>S</given-names></name><name><surname>Kuypers</surname><given-names>J</given-names></name><name><surname>Kokoris</surname><given-names>M</given-names></name><name><surname>Yakir</surname><given-names>B</given-names></name><name><surname>Darvasi</surname><given-names>A</given-names></name></person-group><article-title>Linkage disequilibrium patterns of the human genome across populations</article-title><source>Hum Mol Genet</source><year>2003</year><volume>12</volume><fpage>771</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg088</pub-id><pub-id pub-id-type="pmid">12651872</pub-id></mixed-citation></ref><ref id="CR33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shilling</surname><given-names>HG</given-names></name><name><surname>Guethlein</surname><given-names>LA</given-names></name><name><surname>Cheng</surname><given-names>NW</given-names></name><name><surname>Gardiner</surname><given-names>CM</given-names></name><name><surname>Rodriguez</surname><given-names>R</given-names></name><name><surname>Tyan</surname><given-names>D</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>2307</fpage><lpage>2315</lpage><pub-id pub-id-type="pmid">11859120</pub-id></mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajik</surname><given-names>N</given-names></name><name><surname>Shahsavar</surname><given-names>F</given-names></name><name><surname>Mousavi</surname><given-names>T</given-names></name><name><surname>Radjabzadeh</surname><given-names>MF</given-names></name></person-group><article-title>Distribution of KIR genes in the Iranian population</article-title><source>Tissue Antigens</source><year>2009</year><volume>74</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0039.2009.01263.x</pub-id><pub-id pub-id-type="pmid">19392787</pub-id></mixed-citation></ref><ref id="CR35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yawata</surname><given-names>M</given-names></name><name><surname>Yawata</surname><given-names>N</given-names></name><name><surname>Abi-Rached</surname><given-names>L</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family</article-title><source>Crit Rev Immunol</source><year>2002</year><volume>22</volume><fpage>463</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">12803322</pub-id></mixed-citation></ref><ref id="CR36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yawata</surname><given-names>M</given-names></name><name><surname>Yawata</surname><given-names>N</given-names></name><name><surname>Draghi</surname><given-names>M</given-names></name><name><surname>Little</surname><given-names>AM</given-names></name><name><surname>Partheniou</surname><given-names>F</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1084/jem.20051884</pub-id><pub-id pub-id-type="pmid">16533882</pub-id></mixed-citation></ref><ref id="CR37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yawata</surname><given-names>M</given-names></name><name><surname>Yawata</surname><given-names>N</given-names></name><name><surname>Draghi</surname><given-names>M</given-names></name><name><surname>Partheniou</surname><given-names>F</given-names></name><name><surname>Little</surname><given-names>AM</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response</article-title><source>Blood</source><year>2008</year><volume>112</volume><fpage>2369</fpage><lpage>2380</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-03-143727</pub-id><pub-id pub-id-type="pmid">18583565</pub-id></mixed-citation></ref><ref id="CR38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamudio</surname><given-names>S</given-names></name></person-group><article-title>High-altitude hypoxia and preeclampsia</article-title><source>Front Biosc</source><year>2007</year><volume>12</volume><fpage>2967</fpage><lpage>2977</lpage><pub-id pub-id-type="doi">10.2741/2286</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p>An erratum to this article can be found at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00251-010-0436-1">http://dx.doi.org/10.1007/s00251-010-0436-1</ext-link></p></fn></fn-group></back></article>